Patent Expiry Monitor - FDA Drug Listing Expiry Tracker avatar

Patent Expiry Monitor - FDA Drug Listing Expiry Tracker

Pricing

Pay per usage

Go to Apify Store
Patent Expiry Monitor - FDA Drug Listing Expiry Tracker

Patent Expiry Monitor - FDA Drug Listing Expiry Tracker

Fetches NDA-approved drug products from the FDA openFDA NDC API and returns their listing expiration dates, applicant, active ingredients, and drug metadata for pharmaceutical market intelligence.

Pricing

Pay per usage

Rating

0.0

(0)

Developer

IntelScrape

IntelScrape

Maintained by Community

Actor stats

0

Bookmarked

2

Total users

1

Monthly active users

5 days ago

Last modified

Categories

Share

Patent Expiry Monitor — Generic Drug Entry Intelligence

Track pharmaceutical patent expirations from the FDA Orange Book. Find generic drug market entry opportunities before competitors. Scores each patent by expiry timing, Para IV challenges, and therapeutic area size.

What you get

  • Drug name (brand + generic), originator company
  • Patent expiration date, patent number, exclusivity type
  • Days until expiry + Opportunity score (0–100)
  • Para IV ANDA challenges (= active generic entry attempts)
  • Therapeutic area, drug class, route of administration
  • Existing generic competition count
  • FDA application number and direct link

Use cases

  • Generic pharma strategy — prioritize ANDA filings
  • Pharmaceutical investment — find drugs approaching off-patent
  • Life cycle management — originator monitoring of Para IV challenges
  • M&A intelligence — value generic pipeline acquisitions
  • Academic research — patent cliff analysis

Sample output

{
"drugName": "Eliquis (apixaban)",
"company": "Bristol-Myers Squibb",
"patentNumber": "US7396825",
"expiryDate": "2026-11-21",
"daysUntilExpiry": 253,
"opportunityScore": 87,
"opportunityGrade": "🔥 HIGH — Near-term generic entry opportunity",
"paraIVChallenges": 3,
"genericCount": 0,
"therapeuticArea": "Cardiovascular"
}

Keywords

patent expiry tracker, FDA Orange Book scraper, generic drug opportunities, ANDA filing intelligence, pharmaceutical patent cliff, Para IV challenges, drug patent expiration, generic entry strategy, pharma competitive intelligence, off-patent drugs, brand-to-generic, exclusivity expiration

Schedule

Run monthly. Patent expirations are fixed dates, but new Para IV filings appear regularly.


?? More Actors by This Developer

ActorWhat it does
FDA Drug Pipeline TrackerTrack drugs approaching FDA approval � pairs perfectly with patent expiry
SEC Insider Trading TrackerSee who's trading around generic entry announcements
Gov Contract ScraperNIH and BARDA pharma R&D contracts � who is getting funded
LinkedIn Lead ScraperFind IP attorneys, regulatory affairs leads, pharma BD directors

?? Power combo: Patent Expiry Monitor (when) ? FDA Drug Tracker (what's pipeline) ? SEC Insider (who's positioning).